← All patents

US20220047596A1

Combination of parp inhibitor and brd4 inhibitor for the treatment of cancer

University of Texas System

Abstract

Provided herein are methods of treating cancer comprising administering a PARP inhibitor which may be combined with a BRD4 inhibitor. In one embodiment, the present disclosure provides a method for treating cancer in a subject comprising administering an effective amount of a poly-ADP-ribose …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Gordon B. Mills
Priority date
September 12, 2018
Filing date
September 12, 2019
Publication date
February 17, 2022
Language
en
Metadata fetched
August 29, 2026 00:29